Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Prepaid Assets: 2017-2025

Historic Prepaid Assets for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $15.0 million.

  • Arcus Biosciences' Prepaid Assets fell 31.82% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 31.82%. This contributed to the annual value of $18.0 million for FY2024, which is 47.06% down from last year.
  • Latest data reveals that Arcus Biosciences reported Prepaid Assets of $15.0 million as of Q3 2025, which was down 25.00% from $20.0 million recorded in Q2 2025.
  • Arcus Biosciences' 5-year Prepaid Assets high stood at $34.0 million for Q4 2023, and its period low was $8.7 million during Q1 2021.
  • Moreover, its 3-year median value for Prepaid Assets was $22.0 million (2024), whereas its average is $24.4 million.
  • Per our database at Business Quant, Arcus Biosciences' Prepaid Assets soared by 229.01% in 2021 and then crashed by 47.06% in 2024.
  • Arcus Biosciences' Prepaid Assets (Quarterly) stood at $18.0 million in 2021, then climbed by 5.56% to $19.0 million in 2022, then surged by 78.95% to $34.0 million in 2023, then slumped by 47.06% to $18.0 million in 2024, then tumbled by 31.82% to $15.0 million in 2025.
  • Its Prepaid Assets stands at $15.0 million for Q3 2025, versus $20.0 million for Q2 2025 and $19.0 million for Q1 2025.